Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Pfizer Policy Effort Adjusts To Obama Era: Adds Greg Simon, From Obama Transition

This article was originally published in The Pink Sheet Daily

Executive Summary

Pfizer is aligning its internal policy shop to get more in tune with Democratic Washington. The first major staff change is Greg Simon moving from Faster Cures advocacy group to become senior VP-worldwide policy.

You may also be interested in...



Biotech Equity Crowdfunding Gets A Head Start Overseas

Can crowdfunding fill the biotech capital gap? In the US, new services are jockeying at the starting gate even though the government’s final rules won’t be ready soon, while in Europe the experiment has begun in earnest.

PhRMA Has Labor Support For Extended Biologics Exclusivity

The Sheet Metal Workers' International Association labor union supports the 12-year data exclusivity for biologics embodied in Sen. Edward Kennedy's follow-on biologics bill

The Evolving Door? What Having A ‘Big Data’ Commissioner Might Mean For US FDA

Robert Califf’s nomination to return as FDA commissioner will raise protests about a ‘revolving door’ pathway between industry and agency. But, in this case, it may be more apt to talk about how Califf’s time outside FDA led to evolving views on the role of big data in drug regulation.

Topics

UsernamePublicRestriction

Register

PS069416

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel